Opens 1600L/1000L reactor stream at Oxford, UK and increases API capacity at Verona, Italy Greenwich, CT, April 2, 2015 - Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has increased its ...
Significant increase in capacity to scale of millions of capsules/tablets, new capabilities and addition of commercial drug product license Greenwich, CT, - Aptuit LLC announced it has augmented ...
Pharmaceutical services firm Aptuit has agreed to acquire EaglePicher's pharmaceutical services unit, consisting of active pharmaceutical ingredient plants in Lenexa, Kans., and Harrisonville, Mo., ...
Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has increased its global capacity for Active Pharmaceutical Ingredient (API) Manufacture due to increased demand for API, and for its ...
Aptuit, Inc. today announced that it has completed the acquisition of the Chemical and Pharmaceutical Development (CPD) business of Evotec, which integrates an active pharmaceutical ingredient (API) ...
GREENWICH, Conn.--(BUSINESS WIRE)--Aptuit, Inc. announced today that it has signed an agreement to acquire the assets and operations of EaglePicher Pharmaceutical Services (EPPS) – the first step ...
Jonathan Goldman, CEO of Aptuit LLC, announced today that Henning Steinhagen, PhD, has been named as President, Research and Development Operations. Henning will continue in his existing role of ...
Greenwich, CT, November 8, 2012 – Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & ...
Greenwich, CT, July 15, 2014 -- Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback